Mirae Asset Global Etfs Holdings Ltd. Aldeyra Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 28,592 shares of ALDX stock, worth $158,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,592
Previous 29,840
4.18%
Holding current value
$158,399
Previous $171,000
36.26%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ALDX
# of Institutions
135Shares Held
34.9MCall Options Held
244KPut Options Held
51.6K-
Knoll Capital Management, LLC Miami, FL5.48MShares$30.3 Million14.27% of portfolio
-
Perceptive Advisors LLC New York, NY4.05MShares$22.4 Million0.68% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$20.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$19.4 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT2.05MShares$11.4 Million1.29% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $323M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...